A case of subacute infective endocarditis and blood access infection caused by Enterococcus durans
© Kenzaka et al.; licensee BioMed Central Ltd. 2013
Received: 1 April 2013
Accepted: 10 December 2013
Published: 17 December 2013
Infection by Enterococcus durans (E. durans) is very rare; reported cases are often preceded by therapy or an immunosuppressed state, including infective endocarditis, urinary tract infection, or wound infection. A few reported cases of infective endocarditis exist, with no reports describing involvement of blood access infection.
The patient is an 83-year-old man who had been undergoing hemodialysis for 8 years due to renal failure caused by diabetic nephropathy. He developed infective endocarditis and blood access infection/infective aneurysm due to Enterococcus durans; these conditions were treated with the antibiotic regimen of ampicillin + gentamicin. There have been only a few reported cases of infective endocarditis caused by E. durans, and to our knowledge, this is the first report of blood access infection.
We have experienced a case of concurrent infective endocarditis and blood access infection/infective aneurysm caused by E. durans. This is the world’s first reported case of blood access infection/infective aneurysm by E. durans.
KeywordsEnterococcus durans Infective endocarditis Blood access infection Infective aneurysm
Infection by Enterococcus durans (E. durans) is very rare; reported cases are often preceded by therapy or an immunosuppressed state, including infective endocarditis, urinary tract infection, or wound infection. A few reported cases of infective endocarditis exist, with no reports describing involvement of blood access infection. We report a case of infective endocarditis and blood access infection/infective aneurysm caused by E. durans.
The patient is an 83-year-old man with a 50-year medical history of diabetes; he had been undergoing hemodialysis for 8 years due to renal failure caused by diabetic nephropathy. After repeated shunt failure, the superficialized right brachial artery had been used for blood access for the past 2 years. About 4 months prior to admission, an occasional fever with temperature of 38°C would repeatedly occur after hemodialysis. About 1 month prior to admission, the frequency of fever increased, and levofloxacin and cefotiam were administered but yielded no improvement; the day of dialysis would be followed by an overnight fever of about 38°C accompanied by chills and joint pain. From about 2 weeks prior to presentation, general malaise and loss of appetite was observed; hence, the patient was hospitalized 6 days before the current medical consult. Chest and pelvic CT examination was performed; however, the cause of his fever and chills could not be identified. Enterococcus was detected in a blood culture performed before and after hemodialysis on admission, and the patient was transferred to our hospital for examination and treatment of bacteremia.
Upon admission, blood pressure of the patient was 145/68 mmHg, pulse was 64 beats/min, breathing rate was 20 breaths/min, and body temperature was 37°C. During physical examination, a Levine III/VI systolic ejection murmur was heard in the aortic valve area. No Osler’s nodes or Janeway lesions were observed, and blood from the dialysis puncture site was free of abnormalities.
The laboratory findings were as follows: a white blood cell count of 6,900/μL (neutrophils, 78%); hemoglobin, 10.7 g/dL; platelets, 117,000/μL; C-reactive protein, 3.4 mg/dL; total bilirubin, 0.5 mg/dL; aspartate aminotransferase, 23 IU/L; alanine aminotransferase, 7 IU/L; lactic dehydrogenase, 137 IU/L; gamma-glutamyl transpeptidase, 16 IU/L; creatinine phosphokinase, 34 IU/L; blood urea nitrogen, 26 mg/dL; creatinine, 6.22 mg/dL; Na, 139 mEq/L; K, 4.0 mEq/L; Cl, 101 mEq/L; blood glucose, 148 mg/dL; and hemoglobin A1c (NGSP), 6.0%.
Given the patient's age and long history of diabetes, the patient's blood vessels had incurred significant arterial sclerosis. With a performance status of 3, surgical intervention was not performed, and therapy with antibiotics was the first choice. Antibiotic administration alleviated the fever, and subsequent blood culture testing showed negative results after 6 weeks of treatment. Transesophageal echocardiography performed during the course of treatment confirmed the disappearance of the verruca of the aortic valve. Vascular echocardiography of the brachial artery performed during the course of treatment revealed narrowing of the aneurysm. It also showed the disappearance of the thrombus, without the occurrence of any embolic symptoms. Antimicrobial therapy mitigated the condition, and the clinical diagnosis was a plaque (verruca) associated with an infection. Thus antibiotic administration mitigated the infective endocarditis and blood access infection/infective aneurysm and the patient was discharged. The patient has not relapsed after more than six months after discharge.
Among all Enterococcal infections, 63–81% are classified under E. faecalis and 13-23% are classified under E. faecium; the remainder is other species (E. gallinarum, E. avium, E. casseliflavus, E. raffinosus, E.durans and E. hirae, etc.) . Following streptococci and staphylococci, the enterococci are 3rd most frequent of the bacteria causing infective endocarditis, accounting for about 8% . However, E. durans infection is extremely rare, being reported in only 0.1% of Enterococcal bacteremia . Moreover, worldwide, infective endocarditis caused by E. durans has been reported only in 3 cases ever [6–8]. In turn, being unable to find any reports of blood access infection or infective aneurysm caused by E. durans, we believe that this is the world's first report.E. durans infection is rare and sporadic in other organs, too, but reports do include urinary tract infection  and wound infection . Also, E. durans infection has an easily followed sub-acute progression, and in the present case, the fever lasted for several months. Elderly and immunocompromised patients are more susceptible to Enterococcal infection . Similarly, reports of E. durans infection are also found for immunocompromised patients with cirrhosis  or after renal transplantation , as well as complex infections preceded by some form of therapy [3, 8]. In the present case, as well, the patient’s long-term history of hemodialysis is considered to have been a risk factor. Initially, infection was observed only after hemodialysis, so it is believed that blood access infection of the superficialized brachial artery occurred first, and was then complicated by infective endocarditis from bacteremia.
Transthoracic echocardiography failed to confirm the verruca because of its low sensitivity (43-60%) and the intensity of calcification of the aortic valve. However, transesophageal echocardiography has a sensitivity of 87-100% and specificity of 91-100% , and it was able to confirm the verruca of the aortic valve.
Optimal therapy for IE caused by enterococci requires a synergistic bactericidal combination of a cell-wall-active antimicrobial agent to which the organism is susceptible (penicillin or ampicillin) and an aminoglycoside. In the present case, the E. durans was favorably susceptible to ampicillin and gentamicin, and this concomitant antimicrobial therapy alone was able to improve the infective endocarditis and blood access infection.
To conclude, we have experienced a case of concurrent infective endocarditis and blood access infection/infective aneurysm caused by E. durans. This is the world’s first reported case of blood access infection/infective aneurysm by E. durans.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images.
A copy of the written consent is available for review by the Series Editor of this journal.
- Facklam RR, Collins MD: Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 1989, 27: 731-734.PubMed CentralPubMed
- Knudtson LM, Hartman PA: Routine procedures for isolation and identification of enterococci and fecal streptococci. Appl Environ Microbiol. 1992, 58: 3027-3031.PubMed CentralPubMed
- Ruoff KL, de la Maza L, Murtagh MJ, Spargo JD, Ferraro MJ: Species identities of enterococci isolated from clinical specimens. J Clin Microbiol. 1990, 28: 435-437.PubMed CentralPubMed
- McDonald JR, Olaison L, Anderson DJ, Hoen B, Miro JM, Eykyn S, et al: Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database. Am J Med. 2005, 118: 759-766. 10.1016/j.amjmed.2005.02.020.View ArticlePubMed
- Tan CK, Lai CC, Wang JY, Lin SH, Liao CH, Huang YT, et al: Bacteremia caused by non-faecalis and non-faecium Enterococcus species at a medical center in Taiwan, 2000 to 2008. J Infect. 2010, 61: 34-43. 10.1016/j.jinf.2010.04.007.View ArticlePubMed
- Vijayakrishnan R, Rapose A: Fatal Enterococcus durans aortic valve endocarditis: a case report and review of the literature. BMJ Case Rep. 2012, doi:10.1136/bcr-02-2012-5855
- Stepanović S, Jovanović M, Lavadinović L, Stosović B, Pelemis M: Enterococcus durans endocarditis in a patient with transposition of the great vessels. J Med Microbiol. 2004, 53: 259-261. 10.1099/jmm.0.05382-0.View ArticlePubMed
- Tripodi MF, Locatelli A, Adinolfi LE, Andreana A, Utili R: Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci. Eur J Clin Microbiol Infect Dis. 1998, 17: 734-736. 10.1007/s100960050171.View ArticlePubMed
- Miskeen PA, Deodhar L: Antimicrobial susceptibility pattern of Enterococcus species from urinary tract infections. J Assoc Physicians India. 2002, 50: 378-381.PubMed
- Hall LM, Chen HY, Williams RJ: Vancomycin-resistant Enterococcus durans. Lancet. 1992, 340: 1105-View ArticlePubMed
- Evangelista A, Gonzalez-Alujas MT: Echocardiography in infective endocarditis. Heart. 2004, 90: 614-617. 10.1136/hrt.2003.029868.PubMed CentralView ArticlePubMed
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/13/594/prepub
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.